Allergan Nears Win Over Miotox's $600M Botox Royalty Claim
A California federal judge on Monday tentatively ruled Allergan Inc. owes Miotox LLC royalties on Botox only when it's used in migraine treatments covered by Miotox patents, a ruling that would...To view the full article, register now.
Already a subscriber? Click here to view full article